Firstly it’s important to understand CBD and how it interacts with our ECS. The cannabis plant contains more than 100 known cannabinoids plus an array of terpenes all of which have their own individual characteristics. When taken together we are able to observe a phenomenon known as the entourage effect. This means that the main cannabinoids effects are enhanced by the presence of the other cannabinoids in the plant, resulting in stronger and more effective benefits.
In 2011 the British Journal of Pharmacology did a review of studies on how phytocannabinoids and terpenes work together to improve the therapeutic benefits on pain, anxiety, inflammation, epilepsy, cancer and fungal infection. And in 2018 further research indicates that the terpenes and flavonoids found in the plant can help neurodegenerative (Alzheimer’s, Huntington’s and Parkinson’s disease), neuroinflammatory (sepsis-induced encephalopathy) and neurological disorders.
It’s worth noting that there is also a diminishing return on the isolated products compared to full spectrum products which display a plateau when taking higher doses, giving it greater scope for clinical application.